Business models in the healthcare industry

Our team assisted a pharmaceutical company in the development of a business model for an application to diagnose the different states and severity of depression.

Several models were considered (Free, Freemium, Premium, Paymium) and were evaluated according to patient behavior, price levels and the possibility of reimbursement by insurers in particular.

Each model was analyzed in the form of a complete business case and was the subject of strategic partnership scenarios, which allowed our client to project itself and choose the best model for its application.

We worked with a leading player in the animal health sector who wanted to imagine new business models in connection with new services to be developed. We organized an “inspiration” workshop bringing together players from different sectors such as Butagaz, Xerox, Samsung and Somfy.

This workshop comprised 2 steps: the first one consisted in better understanding the history, the good practices and the key success factors of these inspiring companies’ models, and the second one consisted in co-constructing with our client the most adapted model to their case.

Our approach enabled our client to draw inspiration from other non-competitive players to define an innovative business model that would differentiate themselves from existing models.

A company in the pharmaceutical sector was looking to make the transition to a new value proposition, likely to induce profound changes in its sales functions.

We helped them broaden and challenge their current vision by exploring existing market models, notably through a competitive benchmark, and by analyzing their customers’ needs and expectations.

Our team organized several workshops with our customer’s teams, resulting in a complete set of specifications for the future business and the associated roadmap for the upcoming transition.

We assisted one of our clients, a leading industrial player in healthcare, in the evaluation of a strategic opportunity in the e-health speech disorders market.

To do so, our team conducted a literature review and interviews to identify the players, understand and evaluate the teletherapy market for speech and language disorders. We interviewed potential partners to understand their solutions, their current business models and to evaluate their willingness to partner with our client. For this search for partners, our team developed an interactive Excel tool to describe and visualize the potential partnering models between our client and each of the companies studied.

In the end, our client was able to short-list partners, meet with them and conclude an agreement with one of them.

We supported one of our clients in refining and finalizing their business model and business plan on a biotechnology R&D service infrastructure providing expertise in several synthetic biology technologies.

In a first step we challenged our client’s scenarios about competitive positioning and application markets to focus on. We then identified potential customers and funding options and defined the potential revenue of the platform, nourished by field insights.

In the end, a first version of the business model and business plan was co-constructed and further refined to address both academic and industrial actors.

We supported our client, a company in the biotechnology industry specialized in gene engineering on micro-organisms, in better understanding the potential for microorganism development in the healthcare, cosmetics, food, and feed sectors.

Our team help our client in defining and prioritizing its market by performing interviews with key opinion leaders and representatives of industrial players located in the sectors of interest.

The key expected features were derived in a consistent value proposition, and subsequently a refined business model on the sector with the highest interest was developed.